Leon Wang
Stock Analyst at Barclays
(2.92)
# 1,629
Out of 4,711 analysts
11
Total ratings
71.43%
Success rate
21.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Leon Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $70.44 | -10.56% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $13 → $4 | $0.83 | +384.61% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $52.17 | +13.09% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $70.44
Upside: -10.56%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $13 → $4
Current: $0.83
Upside: +384.61%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $52.17
Upside: +13.09%